TLR3 and colorectal carcinoma: Conversely, activating TLR3 with Poly(I:C) restores immune cell functions, enhancing the antitumor effects of 5-FU, thereby underscoring the potential role of gut virome interactions in optimizing CRC chemotherapy outcomes.